[Federal Register Volume 88, Number 187 (Thursday, September 28, 2023)]
[Notices]
[Pages 66861-66862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21147]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, National Cancer Institute.
    This meeting will be a hybrid meeting held in-person and virtually 
and will be open to the public as indicated below with attendance 
limited to space available. Individuals who plan to attend in-person or 
view the virtual meeting and need special assistance or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting. The open session can be accessed from 
the NIH Videocast at the following link: http://videocast.nih.gov/.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(6), title 
5 U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Cancer Institute, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute.
    Date: November 13, 2023.
    Open: 10:00 a.m. to 10:30 a.m.
    Agenda: Remarks from the NCI Director.
    Closed: 10:30 a.m. to 4:00 p.m.
    Agenda: Personnel qualifications and performance, and competence 
of individual investigators.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute.
    Date: November 14, 2023.
    Closed: 11:00 a.m. to 1:45 p.m.
    Agenda: Personnel qualifications and performance, and competence 
of individual investigators.
    Place: National Institute of Health, Building 31, C Wing, 6th 
Floor, Conference Room C, 9000 Rockville Pike, Bethesda, MD 20892 
(Hybrid Meeting).
    Contact Person: Brian E. Wojcik, Ph.D., Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center Drive, Room 3W414, Rockville, MD 20850, 240-276-5660, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when

[[Page 66862]]

applicable, the business or professional affiliation of the 
interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/bsc/index.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 22, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21147 Filed 9-27-23; 8:45 am]
BILLING CODE 4140-01-P